Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades,” said ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Our Top PicksBest rechargeableJabra EnhanceBest basic optionsMDHearingEasiest insertionEargoHearing loss may affect cognition ...

All products and services featured are independently chosen by editors. However, Flow Space may receive a commission on orders placed through its retail links, and the retailer may receive certain ...